Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A newly certified APRN is beginning independent prescribing in a
primary care clinic. Before writing the first prescription, which action
best demonstrates safe and legally sound prescribing practice?
A. Rely primarily on pharmaceutical representatives for medication
updates
B. Confirm prescriptive authority, state regulatory requirements,
collaborative or supervisory requirements if applicable, and DEA
registration before prescribing controlled substances
C. Prescribe medications only after obtaining physician approval for
every patient encounter
D. Avoid prescribing newly approved medications for the first 10 years
after FDA approval
Correct Answer: B
Rationale: Safe prescribing begins with understanding the legal scope
of practice, state-specific prescribing regulations, DEA requirements for
controlled substances, and applicable collaborative practice
agreements. This foundation protects patient safety and regulatory
compliance. Pharmaceutical representatives should not serve as the
primary source of prescribing information. Physician approval is not
universally required and depends on state law. Avoiding all newly
approved medications for a decade is not evidence-based.
Question 2
An APRN evaluates a 72-year-old woman with hypertension,
osteoarthritis, chronic kidney disease stage 3, and insomnia. She
,currently takes nine medications prescribed by multiple specialists.
Which prescribing approach is most appropriate?
A. Add treatment for every newly identified symptom
B. Review all medications for therapeutic duplication, interactions, and
deprescribing opportunities before initiating additional therapy
C. Continue all current medications because specialists prescribed them
D. Stop every medication except antihypertensive therapy
Correct Answer: B
Rationale: Polypharmacy significantly increases the risk of adverse drug
events, interactions, medication nonadherence, and prescribing
cascades. A comprehensive medication reconciliation with evaluation
for deprescribing opportunities should precede additional prescribing.
Automatically adding medications or discontinuing all therapies without
assessment is inappropriate.
Question 3
An APRN is considering prescribing a medication that has recently
received FDA approval. Which source provides the highest-quality
evidence for evaluating efficacy and safety before prescribing?
A. Patient testimonials on social media
B. Pharmaceutical marketing brochures
C. Peer-reviewed clinical trials, prescribing information, and current
evidence-based clinical guidelines
D. Online discussion forums
Correct Answer: C
, Rationale: Evidence-based prescribing relies on high-quality scientific
evidence, FDA-approved prescribing information, peer-reviewed
literature, and current professional guidelines. Marketing materials and
anecdotal reports are subject to bias and should not guide prescribing
decisions.
Question 4
A patient requests an antibiotic for symptoms consistent with a viral
upper respiratory infection. The patient insists antibiotics helped during
a previous illness. What is the APRN's best response?
A. Prescribe an antibiotic to maintain patient satisfaction
B. Explain why antibiotics are unlikely to help, discuss symptomatic
management, and provide return precautions
C. Prescribe a broad-spectrum antibiotic "just in case"
D. Delay treatment until symptoms worsen
Correct Answer: B
Rationale: Antibiotic stewardship is a core responsibility of prescribers.
Patients should receive education regarding viral illnesses, expected
symptom duration, supportive care, and indications for reevaluation.
Inappropriate antibiotic prescribing contributes to antimicrobial
resistance and avoidable adverse effects.
Question 5
An APRN prescribes an antihypertensive medication. Which
documentation best reflects high-quality prescribing?
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A newly certified APRN is beginning independent prescribing in a
primary care clinic. Before writing the first prescription, which action
best demonstrates safe and legally sound prescribing practice?
A. Rely primarily on pharmaceutical representatives for medication
updates
B. Confirm prescriptive authority, state regulatory requirements,
collaborative or supervisory requirements if applicable, and DEA
registration before prescribing controlled substances
C. Prescribe medications only after obtaining physician approval for
every patient encounter
D. Avoid prescribing newly approved medications for the first 10 years
after FDA approval
Correct Answer: B
Rationale: Safe prescribing begins with understanding the legal scope
of practice, state-specific prescribing regulations, DEA requirements for
controlled substances, and applicable collaborative practice
agreements. This foundation protects patient safety and regulatory
compliance. Pharmaceutical representatives should not serve as the
primary source of prescribing information. Physician approval is not
universally required and depends on state law. Avoiding all newly
approved medications for a decade is not evidence-based.
Question 2
An APRN evaluates a 72-year-old woman with hypertension,
osteoarthritis, chronic kidney disease stage 3, and insomnia. She
,currently takes nine medications prescribed by multiple specialists.
Which prescribing approach is most appropriate?
A. Add treatment for every newly identified symptom
B. Review all medications for therapeutic duplication, interactions, and
deprescribing opportunities before initiating additional therapy
C. Continue all current medications because specialists prescribed them
D. Stop every medication except antihypertensive therapy
Correct Answer: B
Rationale: Polypharmacy significantly increases the risk of adverse drug
events, interactions, medication nonadherence, and prescribing
cascades. A comprehensive medication reconciliation with evaluation
for deprescribing opportunities should precede additional prescribing.
Automatically adding medications or discontinuing all therapies without
assessment is inappropriate.
Question 3
An APRN is considering prescribing a medication that has recently
received FDA approval. Which source provides the highest-quality
evidence for evaluating efficacy and safety before prescribing?
A. Patient testimonials on social media
B. Pharmaceutical marketing brochures
C. Peer-reviewed clinical trials, prescribing information, and current
evidence-based clinical guidelines
D. Online discussion forums
Correct Answer: C
, Rationale: Evidence-based prescribing relies on high-quality scientific
evidence, FDA-approved prescribing information, peer-reviewed
literature, and current professional guidelines. Marketing materials and
anecdotal reports are subject to bias and should not guide prescribing
decisions.
Question 4
A patient requests an antibiotic for symptoms consistent with a viral
upper respiratory infection. The patient insists antibiotics helped during
a previous illness. What is the APRN's best response?
A. Prescribe an antibiotic to maintain patient satisfaction
B. Explain why antibiotics are unlikely to help, discuss symptomatic
management, and provide return precautions
C. Prescribe a broad-spectrum antibiotic "just in case"
D. Delay treatment until symptoms worsen
Correct Answer: B
Rationale: Antibiotic stewardship is a core responsibility of prescribers.
Patients should receive education regarding viral illnesses, expected
symptom duration, supportive care, and indications for reevaluation.
Inappropriate antibiotic prescribing contributes to antimicrobial
resistance and avoidable adverse effects.
Question 5
An APRN prescribes an antihypertensive medication. Which
documentation best reflects high-quality prescribing?
